Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2375]
News [3443]
Articles [281]
Editorials [30]
Conferences [171]
elearning [101]
Additional treatment options impact first-line treatment of mRCC: No
Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France
Additional treatment options impact first-line treatment of mRCC: No ( Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France )
23 Sep 2014
What have we learned? Expert perspectives
Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán
What have we learned? Expert perspectives ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )
23 Sep 2014
From clinical trial to clinical practice: Evidence from the real world
Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid...
From clinical trial to clinical practice: Evidence from the real world ( Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid, Madrid, Spain )
23 Sep 2014
Overview of skin cancer treatments, past, present and future
Prof John Hawk - President of the World Congress on Cancers of the Skin 2014
Overview of skin cancer treatments, past, present and future ( Prof John Hawk - President of the World Congress on Cancers of the Skin 2014 )
11 Sep 2014
Emerging treatments in CLL: Expert Discussion
Prof Robin Foà and Prof Peter Hillmen
Emerging treatments in CLL: Expert Discussion ( Prof Robin Foà and Prof Peter Hillmen )
11 Sep 2014
Thrombosis in adult patients with chronic ITP
Dr Howard Liebman - University of Southern California, Los Angeles, USA
Thrombosis in adult patients with chronic ITP ( Dr Howard Liebman - University of Southern California, Los Angeles, USA )
4 Sep 2014
Treatment options in adult chronic idiopathic thrombocytopenic purpura:...
Prof Aristoteles Giagounidis - St John’s Hospital, Duisburg, Germany
Treatment options in adult chronic idiopathic thrombocytopenic purpura: Introduction ( Prof Aristoteles Giagounidis - St John’s Hospital, Duisburg, Germany )
4 Sep 2014
Quality of life and cost advantages of metronomics and drug repurposing
Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK
Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )
10 Jul 2014
Tackling inequality in access to cancer care and information
Prof Mark Lawler - Queen's University Belfast, Belfast, UK
Tackling inequality in access to cancer care and information ( Prof Mark Lawler - Queen's University Belfast, Belfast, UK )
20 Jun 2014
Gdf -11 a new target to improve anaemia in thalassemia
Prof Olivier Hermine - Université Paris Descartes, Paris, France
Gdf -11 a new target to improve anaemia in thalassemia ( Prof Olivier Hermine - Université Paris Descartes, Paris, France )
20 Jun 2014
Eltrombopag helped reduce bleeding in children with immune thrombocytopenic...
Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK
Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura ( Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK )
20 Jun 2014
Multiple myeloma in the elderly: Expert discussion
Prof Philippe Moreau and Prof Marivi Mateos
Multiple myeloma in the elderly: Expert discussion ( Prof Philippe Moreau and Prof Marivi Mateos )
20 Jun 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation